Bioventix Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Peter Harrison
Algemeen directeur
UK£387.8k
Totale compensatie
Percentage CEO-salaris | 59.3% |
Dienstverband CEO | no data |
Eigendom CEO | 5.7% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 7.6yrs |
Recente managementupdates
Recent updates
Estimating The Fair Value Of Bioventix PLC (LON:BVXP)
Jun 19Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Bioventix (LON:BVXP) Is Increasing Its Dividend To £0.62
Mar 30Bioventix (LON:BVXP) Is Increasing Its Dividend To UK£0.52
Mar 31Should Bioventix PLC (LON:BVXP) Be Part Of Your Dividend Portfolio?
Mar 29Is Now The Time To Put Bioventix (LON:BVXP) On Your Watchlist?
Mar 14What Does Bioventix's (LON:BVXP) CEO Pay Reveal?
Feb 27Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return
Jan 31Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?
Jan 18Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 06Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend
Dec 23Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?
Nov 28Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | UK£388k | UK£230k | UK£8m |
Mar 31 2024 | n/a | n/a | UK£8m |
Dec 31 2023 | n/a | n/a | UK£9m |
Sep 30 2023 | n/a | n/a | UK£9m |
Jun 30 2023 | UK£282k | UK£196k | UK£8m |
Mar 31 2023 | n/a | n/a | UK£8m |
Dec 31 2022 | n/a | n/a | UK£8m |
Sep 30 2022 | n/a | n/a | UK£8m |
Jun 30 2022 | UK£250k | UK£184k | UK£8m |
Mar 31 2022 | n/a | n/a | UK£7m |
Dec 31 2021 | n/a | n/a | UK£7m |
Sep 30 2021 | n/a | n/a | UK£7m |
Jun 30 2021 | UK£304k | UK£178k | UK£7m |
Mar 31 2021 | n/a | n/a | UK£7m |
Dec 31 2020 | n/a | n/a | UK£7m |
Sep 30 2020 | n/a | n/a | UK£7m |
Jun 30 2020 | UK£285k | UK£187k | UK£7m |
Mar 31 2020 | n/a | n/a | UK£7m |
Dec 31 2019 | n/a | n/a | UK£7m |
Sep 30 2019 | n/a | n/a | UK£6m |
Jun 30 2019 | UK£322k | UK£175k | UK£6m |
Mar 31 2019 | n/a | n/a | UK£6m |
Dec 31 2018 | n/a | n/a | UK£6m |
Sep 30 2018 | n/a | n/a | UK£6m |
Jun 30 2018 | UK£358k | UK£165k | UK£6m |
Compensatie versus markt: De totale vergoeding ($USD 485.91K ) Peter } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 736.76K ).
Compensatie versus inkomsten: De beloning van Peter is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Peter Harrison (66 yo)
no data
Tenure
UK£387,779
Compensatie
Mr. Peter John Harrison, MA, serves as the Chief Executive Officer of Bioventix PLC. Mr. Harrison has worked in the field of antibody technology since 1986 and has extensive experience of the development a...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | no data | UK£387.78k | 5.69% £ 11.1m | |
CFO & Director | 4.3yrs | UK£97.33k | 0.021% £ 40.8k | |
Independent Non-Executive Chairman | 20yrs | UK£43.55k | 0.30% £ 581.2k | |
Independent Non-Executive Director | 10.8yrs | UK£30.00k | geen gegevens | |
Independent Non-Executive Director | 1.5yrs | UK£30.00k | geen gegevens |
7.6yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van BVXP wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).